治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3252人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1904926, encodeId=f2ad1904926c6, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet：利尿剂并不是对肥胖高血压患者合理的治疗方案, objectType=article, longId=18322, objectId=a7f3183222b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f3183222b, replyNumber=0, likeNumber=116, createdTime=2013-11-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f3183222b, moduleTitle=Lancet：利尿剂并不是对肥胖高血压患者合理的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f3183222b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904932, encodeId=eb0c1904932f2, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Clin Endocrinol：动态血糖监测有助于优化ACTH和GH缺乏儿童的治疗方案, objectType=article, longId=23686, objectId=e44623686fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e44623686fc, replyNumber=0, likeNumber=79, createdTime=2013-09-09, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e44623686fc, moduleTitle=Clin Endocrinol：动态血糖监测有助于优化ACTH和GH缺乏儿童的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e44623686fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904927, encodeId=26e0190492e7b, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JCO：肺癌的HER2靶向治疗方案应纳入HER2基因检查, objectType=article, longId=18394, objectId=83411839407, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83411839407, replyNumber=0, likeNumber=59, createdTime=2013-07-11, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83411839407, moduleTitle=JCO：肺癌的HER2靶向治疗方案应纳入HER2基因检查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83411839407)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904928, encodeId=b8aa1904928cf, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案, objectType=article, longId=18507, objectId=75c41850e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75c41850e4b, replyNumber=0, likeNumber=78, createdTime=2013-10-23, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75c41850e4b, moduleTitle=Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75c41850e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904918, encodeId=c737190491838, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：靶向抑制血小板以澄清急性冠脉综合征的更佳药物治疗方案, objectType=article, longId=12333, objectId=0acc1233328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0acc1233328, replyNumber=0, likeNumber=84, createdTime=2013-03-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0acc1233328, moduleTitle=NEJM：靶向抑制血小板以澄清急性冠脉综合征的更佳药物治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0acc1233328)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904923, encodeId=974419049235b, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Ann Oncol：HER-2靶向治疗方案对胃癌有效, objectType=article, longId=17917, objectId=c31e1e9173d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c31e1e9173d, replyNumber=0, likeNumber=87, createdTime=2013-07-11, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c31e1e9173d, moduleTitle=Ann Oncol：HER-2靶向治疗方案对胃癌有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c31e1e9173d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904931, encodeId=2f7a1904931da, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=病例分享：HER2阳性晚期胃癌治疗方案, objectType=article, longId=21802, objectId=e03721802cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e03721802cb, replyNumber=0, likeNumber=90, createdTime=2014-03-30, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e03721802cb, moduleTitle=病例分享：HER2阳性晚期胃癌治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e03721802cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904924, encodeId=8cbc1904924ed, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=AACE2013糖尿病治疗方案, objectType=article, longId=18059, objectId=cb611805976, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb611805976, replyNumber=0, likeNumber=70, createdTime=2014-01-19, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb611805976, moduleTitle=AACE2013糖尿病治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb611805976)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904929, encodeId=2e2d19049299e, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Radiother Oncol: 山东大学研究者发现缺氧诱导CDUPRT/5-FC基因治疗方案能特异性靶向缺氧肿瘤细胞, objectType=article, longId=18834, objectId=af961883421, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af961883421, replyNumber=0, likeNumber=70, createdTime=2013-09-17, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af961883421, moduleTitle=Radiother Oncol: 山东大学研究者发现缺氧诱导CDUPRT/5-FC基因治疗方案能特异性靶向缺氧肿瘤细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af961883421)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904920, encodeId=e6a71904920f3, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=CA Cancer J Clin：Oncotype DX HER2检查结果不能作为乳腺癌治疗方案的决策标准, objectType=article, longId=13717, objectId=e27d13e1792, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27d13e1792, replyNumber=0, likeNumber=80, createdTime=2013-09-27, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27d13e1792, moduleTitle=CA Cancer J Clin：Oncotype DX HER2检查结果不能作为乳腺癌治疗方案的决策标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27d13e1792)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904925, encodeId=5ec81904925fa, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Radiother Oncol：放化疗应成为N1小细胞食管癌的最佳治疗方案, objectType=article, longId=18086, objectId=9dba1808679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dba1808679, replyNumber=0, likeNumber=121, createdTime=2013-07-04, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dba1808679, moduleTitle=Radiother Oncol：放化疗应成为N1小细胞食管癌的最佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dba1808679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904914, encodeId=89fd1904914b6, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JNCI：急性淋巴细胞白血病患儿治疗方案损害认知功能, objectType=article, longId=9549, objectId=cc519549d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc519549d1, replyNumber=0, likeNumber=68, createdTime=2013-04-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc519549d1, moduleTitle=JNCI：急性淋巴细胞白血病患儿治疗方案损害认知功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc519549d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904915, encodeId=bc2d1904915b4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：III期临床研究证实晚期鼻咽癌标准治疗方案未使患者获益, objectType=article, longId=10558, objectId=8e311055832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e311055832, replyNumber=0, likeNumber=84, createdTime=2013-07-07, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e311055832, moduleTitle=Lancet Oncol：III期临床研究证实晚期鼻咽癌标准治疗方案未使患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e311055832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904917, encodeId=3139190491e8b, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案, objectType=article, longId=12101, objectId=dd1912101f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd1912101f8, replyNumber=0, likeNumber=100, createdTime=2013-07-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd1912101f8, moduleTitle=JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd1912101f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904916, encodeId=7f661904916f5, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=标准治疗方案中加入阿瓦斯汀可显著延长初诊侵袭性胶质瘤的无进展生存期（AVAglio研究）, objectType=article, longId=11325, objectId=b81e1132569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b81e1132569, replyNumber=0, likeNumber=86, createdTime=2013-06-22, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b81e1132569, moduleTitle=标准治疗方案中加入阿瓦斯汀可显著延长初诊侵袭性胶质瘤的无进展生存期（AVAglio研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b81e1132569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904919, encodeId=8e9f19049196f, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=FDA：替拉瑞韦联合治疗方案或致严重皮肤反应, objectType=article, longId=13662, objectId=739013662af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=739013662af, replyNumber=0, likeNumber=75, createdTime=2012-12-28, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=739013662af, moduleTitle=FDA：替拉瑞韦联合治疗方案或致严重皮肤反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=739013662af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904913, encodeId=05ed190491367, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=刘云鹏教授：晚期胰腺癌的治疗方案探索, objectType=article, longId=9354, objectId=edb393549d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb393549d, replyNumber=0, likeNumber=86, createdTime=2013-02-21, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb393549d, moduleTitle=刘云鹏教授：晚期胰腺癌的治疗方案探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edb393549d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904911, encodeId=2c431904911b4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JCO：NSCLC标准治疗方案不应添加沙利度胺, objectType=article, longId=4084, objectId=cb3b40844d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb3b40844d, replyNumber=0, likeNumber=84, createdTime=2012-10-11, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb3b40844d, moduleTitle=JCO：NSCLC标准治疗方案不应添加沙利度胺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb3b40844d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904912, encodeId=d34519049120e, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Nature reviews：聚焦癌症全新治疗方案, objectType=article, longId=5007, objectId=5872500e3e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5872500e3e, replyNumber=0, likeNumber=55, createdTime=2012-10-23, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5872500e3e, moduleTitle=Nature reviews：聚焦癌症全新治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5872500e3e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904910, encodeId=e8d5190491044, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=慢性淋巴细胞白血病新初始治疗方案研究, objectType=article, longId=2794, objectId=762b2e9464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=762b2e9464, replyNumber=0, likeNumber=89, createdTime=2011-08-21, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=762b2e9464, moduleTitle=慢性淋巴细胞白血病新初始治疗方案研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=762b2e9464)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet：利尿剂并不是对肥胖高血压患者合理的治疗方案

2013-11-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Clin Endocrinol：动态血糖监测有助于优化ACTH和GH缺乏儿童的治疗方案

2013-09-09

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JCO：肺癌的HER2靶向治疗方案应纳入HER2基因检查

2013-07-11

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案

2013-10-23

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：靶向抑制血小板以澄清急性冠脉综合征的更佳药物治疗方案

2013-03-06

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Ann Oncol：HER-2靶向治疗方案对胃癌有效

2013-07-11

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

病例分享：HER2阳性晚期胃癌治疗方案

2014-03-30

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

AACE2013糖尿病治疗方案

2014-01-19

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Radiother Oncol: 山东大学研究者发现缺氧诱导CDUPRT/5-FC基因治疗方案能特异性靶向缺氧肿瘤细胞

2013-09-17

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

CA Cancer J Clin：Oncotype DX HER2检查结果不能作为乳腺癌治疗方案的决策标准

2013-09-27

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Radiother Oncol：放化疗应成为N1小细胞食管癌的最佳治疗方案

2013-07-04

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JNCI：急性淋巴细胞白血病患儿治疗方案损害认知功能

2013-04-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：III期临床研究证实晚期鼻咽癌标准治疗方案未使患者获益

2013-07-07

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案

2013-07-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

标准治疗方案中加入阿瓦斯汀可显著延长初诊侵袭性胶质瘤的无进展生存期（AVAglio研究）

2013-06-22

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

FDA：替拉瑞韦联合治疗方案或致严重皮肤反应

2012-12-28

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

刘云鹏教授：晚期胰腺癌的治疗方案探索

2013-02-21

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JCO：NSCLC标准治疗方案不应添加沙利度胺

2012-10-11

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Nature reviews：聚焦癌症全新治疗方案

2012-10-23

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

慢性淋巴细胞白血病新初始治疗方案研究

2011-08-21

科室
- - 订阅+
  - 更多科室
工具
服务